Last reviewed · How we verify

A Randomised, Double-Masked Study to Compare The Safety and Efficacy of Bilateral 0.5%, 0.1% & 0.01% Atropine Treatment In Controlling Progression of Myopia In Children

NCT00371124 Phase 2/Phase 3 UNKNOWN

The purpose of this study is to find an optimal dose of atropine for preventing the rapid progression of myopia in children by comparing the efficacy, safety and functional impact of binocular treatment with 0.5%, 0.1% and 0.01% atropine and to develop a treatment regimen for the routine management of childhood myopia.

Details

Lead sponsorSingapore National Eye Centre
PhasePhase 2/Phase 3
StatusUNKNOWN
Enrolment400
Start date2006-03

Conditions

Interventions

Primary outcomes

Countries

Singapore